In atherosclerosis models, high-dose omega-3 regimens stabilize plaques and blunt inflammatory remodeling; findings consistent with a reduction in protease-driven matrix degradation (with MMP-9 a recognized contributor to plaque vulnerability). The gene discussed is MMP9; the disease is atherosclerosis.